Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building ...

Monoclonal proteins (antibodies) are made up of joined protein chains – 2 short light chains and 2 longer, heavy chains. In light chain amyloidosis, abnormal plasma cells make too many light chains.

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...

CEPI, the Coalition for Epidemic Preparedness Innovations, yesterday announced a $43.5 million deal with pharmaceutical giant AstraZeneca to advance the development of a novel antibody that could ...

The following is a summary of “Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis,” published in the March 2025 issue of Neurology Neuroimmunology & ...

Harnessing Harbour BioMed's proprietary HCAb-based bispecific antibody technology, �lanc� aims to develop innovative therapies addressing key challenges in current obesity treatment, including muscle ...

Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.

Proteins play a key role in the life sciences -- from basic research and biotechnological applications to the development and manufacturing of pharmaceuticals. Scientists have developed a method that ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical com ...

In this role, Michael will be responsible for formulating and overseeing the global corporate development and growth strategy for Harbour BioMed. In addition, as the Head of Global Alliance, he will ...

Neurofilament light chain (NfL) is a neuronal cytoplasmic protein highly expressed in large calibre myelinated axons. Its levels increase in cerebrospinal fluid (CSF) and blood proportionally to the ...